Phreesia Share Holder Equity 2019-2025 | PHR

Phreesia share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Phreesia Annual Share Holder Equity
(Millions of US $)
2025 $265
2024 $251
2023 $288
2022 $417
2021 $263
2020 $102
2019 $-4
2018 $0
Phreesia Quarterly Share Holder Equity
(Millions of US $)
2025-01-31 $265
2024-10-31 $255
2024-07-31 $251
2024-04-30 $253
2024-01-31 $251
2023-10-31 $265
2023-07-31 $247
2023-04-30 $264
2023-01-31 $288
2022-10-31 $320
2022-07-31 $348
2022-04-30 $381
2022-01-31 $417
2021-10-31 $458
2021-07-31 $487
2021-04-30 $503
2021-01-31 $263
2020-10-31 $270
2020-07-31 $98
2020-04-30 $100
2020-01-31 $102
2019-10-31 $102
2019-07-31 $103
2019-04-30 $0
2019-01-31
2018-10-31 $0
2018-07-31 $0
2018-01-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.483B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.557B 53.26
Tempus AI (TEM) United States $9.312B 0.00
Hims & Hers Health (HIMS) United States $9.304B 97.39
Inspire Medical Systems (INSP) United States $4.724B 73.15
IRhythm Technologies (IRTC) United States $4.334B 0.00
Privia Health (PRVA) United States $2.788B 208.91
Enovis (ENOV) United States $1.951B 12.07
Schrodinger (SDGR) United States $1.898B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Omnicell (OMCL) United States $1.428B 30.80
Azenta (AZTA) United States $1.197B 55.74
10x Genomics (TXG) United States $1.053B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.539B 0.00
Talkspace (TALK) United States $0.527B 313.00
Veradigm (MDRX) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.437B 0.00
TruBridge (TBRG) United States $0.393B 0.00
Claritev (CTEV) United States $0.346B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Pulmonx (LUNG) United States $0.144B 0.00
American Well (AMWL) United States $0.114B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.083B 0.00
CareCloud (CCLD) United States $0.074B 3.18
111 (YI) China $0.070B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00